Symposium 14 - HTLV-1
Tracks
.
Tuesday, September 17, 2019 |
4:00 PM - 5:30 PM |
Meeting Room 2 |
Speaker
Lloyd Einsiedel
Executive Director of Central Australia
Baker Institute
The clinical impact of infection with the Human T cell Leukaemia Virus subtype C in central Australia
4:00 PM - 4:20 PMBiography
Dr Einsiedel is an infectious diseases physician who has been working in Central Australia for more than a decade. Dr Einsiedel has published extensively on HTLV-1 and associated conditions, bringing much needed understanding and attention to this neglected disease within Australia.
Mr James Cooney
Phd Student
The Walter And Eliza Hall Institute
Investigating Preventative and Therapeutic Intervention Strategies Against Human T-Leukaemia Virus 1 (HTLV-1) In a Humanised Mouse Model of Infection
4:20 PM - 4:40 PMBiography
James Cooney is a PhD student in the Pellegrini Laboratory at the Walter and Eliza Hall Institute of Medical Research. His research examines the efficacy of therapeutic interventions for the treatment and prevention of HTLV-1 in a pre-clinical model of disease, with a strong clinical translation focus.
Professor Damian Purcell
Professor of Virology and Theme Leader for Viral Infectious Diseases
Uni Melbourne, Doherty Institute
Novel aspects of the Australian HTLV-1c strains
4:40 PM - 5:00 PMBiography
Damian Purcell is Professor of Virology at the University of Melbourne and theme leader for Viral Infectious Diseases at the Peter Doherty Institute for Infection and Immunity.
Professor Damian Purcell is Professor of Virology at the University of Melbourne and Theme Leader for Viral Infectious Diseases at the Doherty Institute. He was a CJ Martin Fellow at the NIAID, NIH. He studies HIV and HTLV replication and is Chair of the next International HTLV meeting in Melbourne.
Dr Fabiola Martin
Senior Clinical Lecturer
School Of Public Health, University Of Queensland
The Impact of World Health Organisation HTLV-1 Open Letter
5:00 PM - 5:20 PMBiography
Fabiola obtained her undergraduate degree in Medicine at the University of Vienna in 1995 and entered her specialist training in Genitourinary and HIV Medicine after becoming a Member of the Royal College of Physicians, London, UK. She completed her specialist clinical training and obtained her MD(Res) in Human T Leukaemia Virus Type 1 medicine at Imperial College London in 2009. In 2014 she became a fellow of the Higher Education Academy (FHEA) and was invited to join the Royal College of Physicians (FRCP) as a fellow in 2015. In 2019 she joined the Chapter of Sexual Health at Royal Australasian College of Physicians (FAChSHM) as a fellow. She works as a sexual health, HIV and HTLV specialist in Brisbane. Fabiola is also a patient advocate and supervises the www.HTLVaware.com webpage and conceived and lead the WHO Open HTLV Letter writing group aiming to improve the implementation of HTLV-1 public health prevention strategies internationally.
Discussion
Q&A
5:20 PM - 5:30 PMBiography
Co-chair
Charles Gilks
IAS HIV Science Local Co-Chair, Team Australia Lead and ASHM Board Director
UQ
Marisa Gilles
Public Health Physician
WACHS